Clinical trial
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
NCT00227136 · University of Western Ontario, Canada, Other · Terminated
Key facts
| NCT number | NCT00227136 |
|---|---|
| Title | Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion |
| Official title | Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion |
| Lead sponsor | University of Western Ontario, Canada, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoid Tumors, Neuroendocrine Tumors |
| Intervention type | Drug |
| Interventions | 5-Hydroxy-Tryptamine |
| Enrollment | 8 |
| Start date | May 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Apr 13, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: